August 29, 2019 — The American Society for Radiation Oncology (ASTRO) announced the top-rated studies being highlighted ...
A randomized clinical trial of targeted, high-dose radiation for men with oligometastatic prostate cancer has shown the treatment to be an effective and safe option for patients who wish to delay hormone-suppression therapy. The phase II trial found that radiation therapy can generate an immune system response not previously believed possible in this type of cancer. Findings were presented at the 61st Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 15-18, 2019, in Chicago.
Fujifilm SonoSite Inc. and the Allen Institute of Artificial Intelligence (AI2) Incubator, builder of AI-first startups, announced a collaboration to interpret ultrasound images with AI, enabling new ultrasound applications and enhanced accuracy. Fujifilm SonoSite has enlisted assistance from the AI2 Incubator to deploy deep learning models on portable ultrasound products. Together, the AI2 Incubator and Fujifilm SonoSite will work to improve image analysis, allowing for the interpretation of a much wider range of ultrasound scenarios.
Agfa Radiology Solutions delivers diagnostic imaging solutions that set the standard in productivity, safety, clinical ...
The first-ever patient radiation therapy treatments generated with machine learning in the RayStation treatment planning system (TPS) have been conducted. Patients with localized prostate cancer are being treated with the technology at the Princess Margaret Cancer Centre in Toronto, Canada, as part of a comprehensive evaluation study.
Anne Hubbard, MBA, director of health policy for ASTRO, explains the details and purpose of the proposed Radiation ...
Densitas Inc. announced it has won a procurement of its densitas densityai software for deployment in up to 24 breast cancer screening clinics across Germany. These clinics will provide breast density measurements at point of care to identify women for supplemental breast cancer screening as part of the DIMASOS 2 Trial.
In June, the Philips Radiology Experience Tour hit the road to provide healthcare professionals with an opportunity to ...
If researchers could observe drug delivery and its effect on cancer cells in real time, they would be able to tailor treatment options with unprecedented specificity.
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., co-director of the Brain Tumor Center at the ...
Aktina Medical introduced several new products at the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, Sept. 15-18 in Chicago. Featured introductions included PositionPro, a new pitch and roll correction-enabled immobilization system for cranial and head and neck radiotherapy treatments, a new line of thermoplastics and a strapless Respiratory Compression Belt.
This summer, the Philips Radiology Experience Tour has been bringing Philips imaging modalities directly to the ...
Varian announced its ProBeam 360° proton therapy system is now available in a multi-room configuration. The ProBeam 360° system is what Varian calls the smallest multi-room system available for sale, with up to a 30 percent smaller footprint than the company's previous multi-room solution.
Selective mammography screening can provide potentially lifesaving early detection of breast cancer in men who are at high risk for the disease, according to a landmark study published in the journal Radiology.
During its annual meeting in September, the American Society for Radiation Oncology (ASTRO) issued a response to the Centers for Medicare and Medicaid Services’ (CMS) request for comment on a proposed advanced alternative payment model (APM) for radiation oncology. The statement, attributed to Paul Harari, M.D., chair of the ASTRO board of directors, listed several areas of concern where the association felt the proposed model falls short.
The healthcare industry faces many different types of obstacles in today’s challenging marketplace. Staff shortages ...
Adding precisely aimed, escalated doses of radiation after patients no longer respond to immunotherapy reinvigorates the immune system in some patients with metastatic non-small-cell lung cancer (NSCLC), increasing progression-free survival (PFS). Findings of the phase II randomized trial were presented at the 61st Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 15-18 in Chicago.
September 18, 2019 — Although Medicare claims data confirm the increasing role of nurse practitioners and physician ...
The European Society of Cardiology (ESC) published new guidelines on the diagnosis and management of chronic coronary syndromes (CCS), which classifies computed tomography angiography (CTA) as a Class 1 recommendation for diagnosing CAD in symptomatic patients. The document, which is a continuation of the 2013 stable coronary artery disease (CAD) guidelines, updates the term to CCS to emphasize the dynamic nature of the disease. It was released at the 2019 ESC Congress, Aug. 31-Sept. 4 in Paris, France, and published simultaneously in the European Heart Journal.
IBA (Ion Beam Applications SA, held its third Victoria Consortium Meeting focusing on Flash irradiation at the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, Sept. 15-18 in Chicago.
The U.S. Food and Drug Administration (FDA) has cleared the Artis icono, a high-precision family of angiography systems from Siemens Healthineers that permit a wide range of minimally invasive procedures to be performed in a single interventional suite. The Artis icono biplane system is engineered for optimal utilization in neuroradiology and abdominal imaging, while the Artis icono floor is a floor-mounted, single-plane system for vascular, interventional cardiology, surgical and oncology procedures. Both systems in the Artis icono family expand the reach of precision medicine.
September 17, 2019 — Treating high-risk heart patients with a single, high dose of radiation therapy can dramatically ...
At the 2019 American Society for Radiation Oncology (ASTRO) Annual Meeting, running Sept. 15-18 in Chicago, Sun Nuclear Corp. will present novel advancements in radiation oncology quality management.
At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, being held Sept. 15-18 in Chicago, Varian announced Ethos therapy, an artificial intelligence (AI)-driven holistic solution designed to increase the capability, flexibility and efficiency of radiotherapy. This new solution is designed to deliver an entire adaptive treatment in a typical 15-minute timeslot, from patient setup through treatment delivery.